Unique ID issued by UMIN | UMIN000030891 |
---|---|
Receipt number | R000035253 |
Scientific Title | An evaluation study of enhancing effect of the absorption of nutrients from carotenoid concentrates by consumption of dairy products |
Date of disclosure of the study information | 2018/01/20 |
Last modified on | 2018/04/13 08:49:54 |
An evaluation study of enhancing effect of the absorption of nutrients from carotenoid concentrates by consumption of dairy products
An evaluation study of enhancing effect of the absorption of nutrients from carotenoid concentrates by consumption of dairy products
An evaluation study of enhancing effect of the absorption of nutrients from carotenoid concentrates by consumption of dairy products
An evaluation study of enhancing effect of the absorption of nutrients from carotenoid concentrates by consumption of dairy products
Japan |
Healthy subjects
Not applicable | Adult |
Others
NO
To confirm the enhancing effect of the absorption of nutrients by consumption of dairy products
Bio-availability
Plasma beta-carotene level
Plasma lycopene, lutein, alpha-carotene, zeaxanthin levels
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Placebo
2
Prevention
Food |
Subjects consume the active food once a day. After the washout period (from 13 days to 20 days), subjects consume the placebo food once a day.
Subjects consume the placebo food once a day. After the washout period (from 13 days to 20 days), subjects consume the active food once a day.
20 | years-old | <= |
35 | years-old | >= |
Male
1) Subjects giving written informed consent
2) Males aged 20 to 35 years old when consent acquisition
3) Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2
1) Subjects who routinely use pharmaceuticals, quasi-drugs, dietary supplement, food for specified health uses, supplements containing carotenoids more than two days per week, or during this study period
2)Subjects who have chronic diseases and administer treatments and medications
3) Subjects who have abnormal lipid metabolism, glucose metabolism, liver function, or kidney function
4) Subjects who have food allergy
5) Subjects who have lactose intolerance
6) Subjects who operated digestive surgical.
7) Subjects who habitually smoke within a month
8) Subjects who participated in other clinical trials within a month or plan to participate other clinical trials during this study period
9) Others who have been determined ineligible by principal investigator or sub-investigator.
10
1st name | |
Middle name | |
Last name | Yukio Asami |
Meiji Co., Ltd.
Food Microbiology Research Laboratories, R&D Division
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5822
yukio.asami@meiji.com
1st name | |
Middle name | |
Last name | Tomoyuki Fukasawa |
Meiji Co., Ltd.
Food Microbiology Research Laboratories, R&D Division
1-29-1 Nanakuni, Hachiouji, Tokyo
042-632-5822
tomoyuki.fukasawa@meiji.com
Meiji Co., Ltd.
Meiji Co., Ltd.
Profit organization
NO
2018 | Year | 01 | Month | 20 | Day |
Unpublished
Completed
2017 | Year | 12 | Month | 25 | Day |
2018 | Year | 02 | Month | 05 | Day |
2018 | Year | 01 | Month | 19 | Day |
2018 | Year | 04 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035253